CSIMarket



Eli Lilly And Company  (LLY)
Other Ticker:  
 
 

LLY's Operating Income Growth by Quarter and Year

Eli Lilly And's Operating Income results by quarter and year




LLY Operating Income (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December - 1,917.20 1,992.10 1,400.20
III Quarter September - 1,881.20 1,278.30 1,430.70
II Quarter June - 1,403.40 1,196.80 1,498.30
I Quarter March 2,404.30 1,155.30 1,590.80 645.10
FY   2,404.30 6,357.10 6,058.00 4,974.30



LLY Operating Income first quarter 2022 Y/Y Growth Comment
Eli Lilly And Company achieved in the first quarter 2022, above Company average Operating Income surge of 108.11% year on year, to $ 2,404.30 millions.

According to the results reported in the first quarter 2022, Eli Lilly And Company achieved the best Operating Income growth in Major Pharmaceutical Preparations industry. While Eli Lilly And Company' s Operating Income doubling of 108.11% ranks overall at the positon no. 54 in the first quarter 2022.

Explain Operating Income growth


LLY Operating Income ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter December - -3.76 % 42.27 % 343.8 %
III Quarter September - 47.16 % -10.65 % 0.3 %
II Quarter June - 17.26 % -20.12 % -
I Quarter March 108.11 % -27.38 % 146.6 % -53.03 %
FY   - 4.94 % 21.79 % 61.39 %

Financial Statements
Eli Lilly And's first quarter 2022 Operating Income $ 2,404.30 millions LLY's Income Statement
Eli Lilly And's first quarter 2021 Operating Income $ 1,155.30 millions Quarterly LLY's Income Statement
New: More LLY's historic Operating Income Growth >>


LLY Operating Income (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter December - 1.91 % 55.84 % -2.13 %
III Quarter September - 34.05 % 6.81 % -4.51 %
II Quarter June - 21.47 % -24.77 % 132.26 %
I Quarter March 25.41 % -42.01 % 13.61 % 104.47 %
FY (Year on Year)   - 4.94 % 21.79 % 61.39 %




Operating Income first quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #1
Healthcare Sector #1
Overall #54

Operating Income Y/Y Growth Statistics
High Average Low
396.16 % 9.62 % -37.37 %
(Dec. 31, 2009)   (Jun 30 2018)
Operating Income first quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #1
Healthcare Sector #1
Overall #54
Operating Income Y/Y Growth Statistics
High Average Low
396.16 % 9.62 % -37.37 %
(Dec. 31, 2009)   (Jun 30 2018)

Operating Income by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Eli Lilly And's Q/Q Operating Income Growth


Operating Income Q/Q Growth Statistics
High Average Low
2642.73 % 57.79 % -94.74 %
(Jun 30 2017)  


LLY's I. Quarter Q/Q Operating Income Comment
Eli Lilly And Company achieved in the I. Quarter 2022 below company average Operating Income jump of 25.41% quarter on quarter, to $ 2,404.30 millions.

I. Quarter 2022 Operating Income sequential growth seem to be contradictory, although beneath the regular, yet it shows a quite recovery relative to the -42.01% in the I. Quarter 2021.

Within Major Pharmaceutical Preparations industry Eli Lilly And Company achieved highest sequential Operating Income growth. While Eli Lilly And's Operating Income growth quarter on quarter, overall rank is 113.


Operating Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #1
Healthcare Sector #5
Overall #113
Operating Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #1
Healthcare Sector #5
Overall #113
Operating Income Q/Q Growth Statistics
High Average Low
2642.73 % 57.79 % -94.74 %
(Jun 30 2017)  


LLY's I. Quarter Q/Q Operating Income Comment
Eli Lilly And Company achieved in the I. Quarter 2022 below company average Operating Income jump of 25.41% quarter on quarter, to $ 2,404.30 millions.

Albeit the I. Quarter 2022 LLY's Operating Income quarter on quarter growth was beneath the regular , it has been still promising news, as the I. Quarter improvement, transcends the -42.01% Operating Income growth in the I. Quarter a year ago

Within Major Pharmaceutical Preparations industry Eli Lilly And Company achieved highest sequential Operating Income growth. While Eli Lilly And's Operating Income growth quarter on quarter, overall rank is 113.


Eli Lilly And's 12 Months Operating Income Growth Year on Year


Operating Income TTM Growth

12 Months Ending
(Mar 31 2022)
12 Months Ending
(Dec 31 2021)
12 Months Ending
(Sep 30 2021)
12 Months Ending
(Jun 30 2021)
12 Months Ending
(Mar 31 2021)
Cumulative Operating Income 12 Months Ending $ 7,606.10 $ 6,357.10 $ 6,432.00 $ 5,829.10 $ 5,622.50
Y / Y Operating Income Growth (TTM) 35.28 % 4.94 % 17.67 % 3.75 % -5.03 %
Year on Year Operating Income Growth Overall Ranking # 184 # 672 # 1269 # 726 # 1365
Seqeuential Operating Income Change (TTM) 19.65 % -1.16 % 10.34 % 3.67 % -7.19 %
Seq. Operating Income Growth (TTM) Overall Ranking # 54 # 700 # 908 # 1663 # 1943




Cumulative Operating Income growth Comment
Eli Lilly And saw improvement in Operating Income growth trend, posting cumulative 12 months Operating Income growth of 35.28% year on year, to $ 7,606 millions if the fiscal year would have ended in Mar 31 2022.
Eli Lilly And's trailing twelve months Operating Income growth was higher than company's average 14.97% and higher than 4.94% growth in Dec 31 2021. And, Eli Lilly And realized the fastest Operating Income growth, in Major Pharmaceutical Preparations industry.
But from the previous reporting period increase was slower at 19.65 % from $6357.1 millions reported in twelve months ending a quarter Dec 31 2021.
Still it was validation of positive momentum, as the typical Q/Q TTM gain stands at 9.62%.
The growth was much higher from twelve months ended Dec 31 2021 exhibited at 19.65 % increase from $6357.1 millions in twelve months ending a quarter before.

Among companies within the Healthcare sector 11 other companies have achieved higher trailing twelve month Operating Income growth. While Total ranking has impoved so far to 184, from total ranking in previous quarter at 672.

Operating Income TTM Q/Q Growth Statistics
High Average Low
396.16 %
9.62 %
-37.37 %
 

Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 1
Healthcare Sector # 12
Overall # 184

Operating Income TTM Y/Y Growth Statistics
High Average Low
458.23 %
14.97 %
-62.4 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 1
Sector # 1
S&P 500 # 54
Cumulative Operating Income growth Comment
Eli Lilly And saw improvement in Operating Income growth trend, posting cumulative 12 months Operating Income growth of 35.28% year on year, to $ 7,606 millions if the fiscal year would have ended in Mar 31 2022.
Eli Lilly And's trailing twelve months Operating Income growth was higher than company's average 14.97% and higher than 4.94% growth in Dec 31 2021. And, Eli Lilly And realized the fastest Operating Income growth, in Major Pharmaceutical Preparations industry.
But from the previous reporting period rise was beneth at 19.65 % from $6357.1 millions reported in twelve months ending a quarter before Xavier Edwards continued.
Still this was confirmation of convincing trend, as the average sequential gain is at 9.62%.
The growth was even more impressive from twelve months ended Dec 31 2021 showed at 19.65 % rise from $6357.1 millions in twelve months ending a quarter before.

Among companies within the Healthcare sector 11 other companies have achieved higher trailing twelve month Operating Income growth. While Total ranking has impoved so far to 184, from total ranking in previous quarter at 672.

Operating Income TTM Q/Q Growth Statistics
High Average Low
396.16 %
9.62 %
-37.37 %
 


Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 1
Healthcare Sector # 12
Overall # 184

Operating Income TTM Y/Y Growth Statistics
High Average Low
458.23 %
14.97 %
-62.4 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 1
Sector # 1
S&P 500 # 54




Other Operating Income Growth
Major Pharmaceutical Preparations Industry Operating Income Growth Trends and Statistics
Healthcare Sector Operating Income Growth Statistics
Operating Income Growth Trends for overall market
LLY's Operating Income Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Operating Income Growth
Lowest Ranking Operating Income Growth
Operating Income Growth for LLY's Competitors
Operating Income Growth for Eli Lilly And's Suppliers
Operating Income Growth for LLY's Customers

You may also want to know
LLY's Annual Growth Rates LLY's Profitability Ratios LLY's Asset Turnover Ratio LLY's Dividend Growth
LLY's Roe LLY's Valuation Ratios LLY's Financial Strength Ratios LLY's Dividend Payout Ratio
LLY's Roa LLY's Inventory Turnover Ratio LLY's Growth Rates LLY's Dividend Comparisons



Companies with similar Operating Income jump for the quarter ending Mar 31 2022 within Healthcare SectorY/Y Change %Operating Income for the quarter ending Mar 31 2022
Quidel Corporation176.85%$ 176.845 millions
Acadia Healthcare Company Inc 170.47%$ 170.468 millions
Insulet Corporation132.52%$ 132.515 millions
Amphastar Pharmaceuticals Inc 109.72%$ 109.722 millions
Eli Lilly And Company108.11%$ 108.110 millions
Harmony Biosciences Holdings inc 89.61%$ 89.610 millions
Merck and Co Inc 84.77%$ 84.771 millions
Maravai Lifesciences Holdings Inc 81.05%$ 81.050 millions
Option Care Health Inc 79.57%$ 79.573 millions
Catalyst Pharmaceuticals Inc 77.19%$ 77.186 millions
Iradimed Corp73.04%$ 73.040 millions
Viemed Healthcare Inc 68.77%$ 68.769 millions
Repligen Corp64.91%$ 64.912 millions
Surgery Partners Inc 56.14%$ 56.143 millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

DBVT's Profile

Stock Price

DBVT's Financials

Business Description

Fundamentals

Charts & Quotes

DBVT's News

Suppliers

DBVT's Competitors

Customers & Markets

Economic Indicators

DBVT's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071